Four Generic Drug Makers Tell Senate Committee the Government Holds Keys to Reshoring Critical Drugs

Four Generic Drug Makers Tell Senate Committee the Government Holds Keys to Reshoring Critical Drugs

The Senate Special Committee on Aging was back at it this week discussing the woeful predicament of the domestic generic drug industry and its import-facing supply chain. This time, the Committee heard from four generic drug makers opposed to advocacy groups and Washington think tanks.

CPA Calls for Replacing USMCA with Two Bilateral Agreements to Restore U.S. Trade Sovereignty

CPA Calls for Replacing USMCA with Two Bilateral Agreements to Restore U.S. Trade Sovereignty

CPA’s submission, “Ensuring U.S. Sovereignty in North American Trade,” concludes that the current trilateral USMCA framework binds two vastly different economies to one unenforceable system—with each reliant on the far larger U.S. consumer market.

CPA Releases New Economics Report: “Section 232 Steel Tariffs Are Necessary For National Security”

CPA Releases New Economics Report: “Section 232 Steel Tariffs Are Necessary For National Security”

The report, titled “Section 232 Steel Tariffs are Necessary for National Security,” highlights how the Trump administration’s Section 232 tariffs have revitalized American manufacturing, created jobs, and strengthened national security.

Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma

Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma

Witnesses at a Senate hearing on Wednesday, Oct. 29 titled “The Future of Biotech” discussed ways to facilitate reshoring and making it attractive to expand in the U.S. and conduct R&D here instead of in China.

With China Agreement Complete, CPA Urges Trump Administration to Prioritize 232 Investigations and Domestic Producers

With China Agreement Complete, CPA Urges Trump Administration to Prioritize 232 Investigations and Domestic Producers

President Trump has already made the most important deal of his life—his promise to the American people to end U.S. dependence on China and rebuild our domestic industrial capacity.